Octagon Therapeutics Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Employees
-
14
- Latest Deal Type
-
Out of Business
Octagon Therapeutics General Information
Description
Developer of targeted immunomodulator medicines intended to reset immune homeostasis in patients with chronic autoimmune and inflammatory disease. The company's medicines pioneer a selective immunomodulation approach based on glycol-immune checkpoint receptors that precisely target disease-driving immune processes, enabling patients to avoid chronic immunosuppression by selectively targeting dysregulated immune cells.
Contact Information
Website
www.octagontherapeutics.comCorporate Office
- 225 Dyer Street
- Providence, RI 02903
- United States
Corporate Office
- 225 Dyer Street
- Providence, RI 02903
- United States
Octagon Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Out of Business | 29-Apr-2025 | Completed | Out of Business | |||
| 10. Later Stage VC | 12-Feb-2024 | Completed | Pre-Clinical Trials | |||
| 9. Later Stage VC | 01-Jan-2023 | Completed | Pre-Clinical Trials | |||
| 8. Seed Round | 01-Dec-2022 | Completed | Pre-Clinical Trials | |||
| 7. Accelerator/Incubator | 01-Oct-2022 | Completed | Pre-Clinical Trials | |||
| 6. Seed Round | 17-Nov-2021 | Completed | Pre-Clinical Trials | |||
| 5. Accelerator/Incubator | 18-Oct-2019 | Completed | Pre-Clinical Trials | |||
| 4. Seed Round | 15-Feb-2018 | Completed | Pre-Clinical Trials | |||
| 3. Accelerator/Incubator | 23-Aug-2017 | Completed | Pre-Clinical Trials | |||
| 2. Accelerator/Incubator | 01-Jun-2017 | Completed | Pre-Clinical Trials |
Octagon Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed-2 |
Octagon Therapeutics Comparisons
Industry
Financing
Details
Octagon Therapeutics Competitors (5)
One of Octagon Therapeutics’s 5 competitors is Argenx, a Formerly VC-backed company based in Zwijnaarde, Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Argenx | Formerly VC-backed | Zwijnaarde, Belgium | ||||
| Ucb Pharma (Poland) | Corporation | Warsaw, Poland | ||||
| AbbVie | Corporation | North Chicago, IL | ||||
| Novartis | Corporation | Basel, Switzerland | ||||
| Sanofi | Corporation | Gentilly, France |
Octagon Therapeutics Patents
Octagon Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2024192243-A2 | Binding agents for treatment of autoimmune conditions | Inactive | 15-Mar-2023 | ||
| WO-2024192243-A3 | Binding agents for treatment of autoimmune conditions | Inactive | 15-Mar-2023 | ||
| WO-2024158832-A2 | Detection and treatment of immune conditions | Inactive | 23-Jan-2023 | ||
| WO-2024158832-A3 | Detection and treatment of immune conditions | Inactive | 23-Jan-2023 | ||
| US-20240350649-A1 | Treatment and diagnosis of immune disorders relating to aberrant immune cells | Pending | 05-Aug-2021 | A61K47/68 |
Octagon Therapeutics Signals
Octagon Therapeutics FAQs
-
When was Octagon Therapeutics founded?
Octagon Therapeutics was founded in 2016.
-
Where is Octagon Therapeutics headquartered?
Octagon Therapeutics is headquartered in Providence, RI.
-
What is the size of Octagon Therapeutics?
Octagon Therapeutics has 14 total employees.
-
What industry is Octagon Therapeutics in?
Octagon Therapeutics’s primary industry is Drug Discovery.
-
Is Octagon Therapeutics a private or public company?
Octagon Therapeutics is a Private company.
-
What is Octagon Therapeutics’s current revenue?
The current revenue for Octagon Therapeutics is .
-
How much funding has Octagon Therapeutics raised over time?
Octagon Therapeutics has raised $14M.
-
Who are Octagon Therapeutics’s competitors?
Argenx, Ucb Pharma (Poland), AbbVie, Novartis, and Sanofi are competitors of Octagon Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process